Medicus Secures United Arab Emirates DOH Authorization For Phase 2a Teverelix Trial In Endometriosis

Medicus Pharma's Phase 2a PRECISION-E2 trial of Teverelix for endometriosis received Investigational New Drug authorization from Abu Dhabi's Department of Health.